Cartesian Therapeutics Inc. (RNAC)
NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 6.68 0.00%
RNAC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $202.11M
- EPS (TTM)
- -$5.78
- Dividend yield
- None
- 52-week range
- 5.60 – 11.00
- Day range
- 6.60 – 6.84
- Volume / Avg
- 86.41K / 133.29K
- Beta
- —
- Shares outstanding
- 30.26M
- Next earnings
- Nov 5, 2026
52-week range
RNAC stock today
Cartesian Therapeutics (RNAC) closed at $6.68 on Oct 7, down 1.04% (-$0.07), versus the S&P 500's 0.22% decline. At this level, RNAC sits near the bottom of its 52-week range of $5.60 to $11.00: 39.3% below the high, set on Jun 24, 2026 and 19.3% above the low. RNAC is down 7.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 31.4%.
Cartesian Therapeutics has posted a net loss over the last twelve months (EPS of -$5.78), so its P/E ratio is not meaningful. Cartesian Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Cartesian Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2016
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-1.02
Cartesian Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LYELLyell Immunopharma Inc. | 8.56 | -0.58% | $209.76M | vs RNAC |
| ELDNEledon Pharmaceuticals Inc. | 2.42 | -1.22% | $196.65M | vs RNAC |
| WHWKWhitehawk Therapeutics Inc. | 3.41 | -5.54% | $194.40M | vs RNAC |
| SIONSionna Therapeutics Inc. | 4.82 | +1.47% | $217.62M | vs RNAC |
| TRDAEntrada Therapeutics Inc. | 5.61 | +3.51% | $218.43M | vs RNAC |
| ADAGAdagene Inc. ADR | 2.81 | -4.10% | $188.67M | vs RNAC |
| NGENNervGen Pharma Corp. | 1.74 | -0.57% | $187.09M | vs RNAC |
| NATRNature's Sunshine Products Inc. | 12.59 | +0.40% | $221.53M | vs RNAC |
Indexes, lists and sector
Cartesian Therapeutics stock FAQ
What is Cartesian Therapeutics's stock price today?
RNAC last traded at $6.68 as of Oct 7, 4:00 PM EDT, down 1.04% on the day. Prices are delayed at least 15 minutes.
Does Cartesian Therapeutics pay a dividend?
No. Cartesian Therapeutics does not currently pay a regular cash dividend.
When is Cartesian Therapeutics's next earnings date?
Cartesian Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-1.02.
Has RNAC ever split its stock?
Yes. The most recent RNAC stock split was a 1-for-30 split on Apr 5, 2024.
What is the RNAC 52-week high?
The 52-week high for RNAC is $11.00 and the 52-week low is $5.60. The stock is currently 39.3% below its high.